Sunesis Pharmaceuticals, Inc. and Chiesi Farmaceutici S.p.A have entered into a research collaboration to discover and develop small molecules that inhibit a well-validated protein-protein target involved in immunological diseases. Using its proprietary discovery technology, Sunesis will generate development candidates and Chiesi will have an exclusive option to enter into an exclusive license to develop and Read more about Sunesis And Chiesi Enter Drug Discovery Agreement[…]